Addex Therapeutics Ltd Stock
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0420 CHF | +3.45% |
|
-2.33% | -24.19% |
| Market Cap | 5.01M 6.19M 5.38M 4.6M 8.69M 591M 8.82M 59.07M 23.18M 294M 23.26M 22.75M 987M | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 4.21M 3.66M 3.13M 5.91M 402M 6M 40.17M 15.76M 200M 15.82M 15.47M 671M | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
43.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Addex Therapeutics Ltd
| 1 day | +3.45% | ||
| 1 week | -2.33% | ||
| 1 month | +1.94% | ||
| 3 months | -15.32% | ||
| 6 months | -15.66% | ||
| Current year | -24.19% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.04 |
| Current year | 0.03 | | 0.06 |
| 1 year | 0.03 | | 0.08 |
| 3 years | 0.03 | | 0.26 |
| 5 years | 0.03 | | 1.63 |
| 10 years | 0.03 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 01/06/2013 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 01/06/2017 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 28/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 01/01/2015 |
Ray Hill
BRD | Director/Board Member | 81 | 12/05/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 A | Other | Director | 269,561 | 0.1233% | ||
| 3/18/26 A | Other | HEAD OF TRANSLATIONAL SCIENCE | 506,765 | 0.2318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.45% | -2.33% | -28.81% | -53.33% | 6.19M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | |
| Average | -1.00% | +0.71% | +52.05% | +73.31% | 25.04B | |
| Weighted average by Cap. | -1.60% | +2.03% | +79.78% | +108.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 507K 441K 376K 711K 48.38M 722K 4.83M 1.9M 24.08M 1.9M 1.86M 80.76M | 173K 214K 186K 159K 300K 20.39M 304K 2.04M 800K 10.15M 802K 785K 34.04M |
| Net income | 7.06M 8.72M 7.58M 6.48M 12.23M 832M 12.42M 83.17M 32.64M 414M 32.75M 32.03M 1.39B | -6.73M -8.32M -7.23M -6.18M -11.67M -794M -11.85M -79.31M -31.13M -395M -31.23M -30.54M -1.33B |
| Net Debt | -3.3M -4.08M -3.55M -3.03M -5.72M -389M -5.81M -38.9M -15.27M -194M -15.32M -14.98M -650M | -1.6M -1.98M -1.72M -1.47M -2.78M -189M -2.82M -18.91M -7.42M -94.21M -7.44M -7.28M -316M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CHF 0.0420 | +3.45% | 244,650 |
| 30/07/26 | CHF 0.0406 | -1.46% | 312,276 |
| 29/07/26 | CHF 0.0412 | +1.98% | 249,571 |
| 28/07/26 | CHF 0.0404 | +0.50% | 140,781 |
| 27/07/26 | CHF 0.0402 | -6.51% | 90,614 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
